Oct 15, 2025 16:15
SANA - Sana Biotechnology, Inc. Common Stock
| Day | 1m | 10m | 60m | PreMarket | Market | AfterHours | Gap |
|---|---|---|---|---|---|---|---|
| 3.25 0.06 (2.0%) | 0.0 (0.0%) | -0.01 (-0.3%) | -0.04 (-1.04%) | -0.03 (-0.92%) | 0.1 (3.27%) | -0.09 (-2.74%) | -0.07 (-2.13%) |
Sana Biotechnology Inc is a biotechnology company. The company develops engineered cells as medicines and therapies to treat diseases. It is engaged in developing cell engineering programs for across a broad array of therapeutic areas with unmet treatment needs, including oncology, diabetes, B-cell-mediated autoimmune, and central nervous system (CNS) disorders, among others. Its pipeline of product candidates is comprised of SC291, SC262, SC255, UP421 and others.
Market Period:
Market
Earnings & Ratios
- Basic EPS:
- -0.39
- Diluted EPS:
- -0.39
- Basic P/E:
- -8.5
- Diluted P/E:
- -8.5
- RSI(14) 1m:
- 45.69
- VWAP:
- 3.32
- RVol:
Events
| Period | Kind | Movement | Occurred At |
|---|
Related News
Aug 27, 2025 11:00
Aug 07, 2025 03:24
Aug 07, 2025 03:24
Jul 15, 2025 08:00
May 19, 2025 14:22
May 14, 2025 18:50
May 12, 2025 13:50
May 11, 2025 13:40
May 04, 2025 20:00